IMGENEX India is developing affordable biosimilars to substitute high-cost branded biologics, alongside diagnostic kits used in clinical practice. Browse our therapeutic pipeline and diagnostic products below.
Originator: Co-developed by IMGENEX India and ICMR-RMRC, Bhubaneswar
Lateral flow chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigen in human nasopharyngeal swabs. Co-developed with ICMR-RMRC, Bhubaneswar.
Learn more
Originator: Co-developed with NIIH-ICMR, Mumbai
Indigenous diagnostic kit to detect common Indian beta-thalassemia mutations. Released by ICMR in collaboration with National Institute Immunohematology, Mumbai.
Learn more